This finding may again suggest a tumor suppressor role for these miRNAs via CDK2 and MCM5,28 which is enhanced early in PSC progression and may become exhausted later in disease or when the condition is exacerbated by hd-UDCA treatment. This evidence concerns the gene CDK2 and neoplasm.